Risk factors for pneumonitis in solid tumors treated with anti-programmed death-1 therapy: A case-control study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e15132
Abstract: e15132Background: Despite its great efficacy in patients with solid tumors, immune checkpoint blockade (ICB) might also lead to a series of inflammatory effects known as immune-related adverse even... read more here.
Keywords: solid tumors; factors pneumonitis; risk factors; treated anti ... See more keywords